Beneficial effect of aspirin against interferon-α-2b-induced depressive behavior in Sprague Dawley rats

The Effect of Newer Serotonin-Noradrenalin Antidepressants on Cytokine Production: A Review of the Current Literature

(2017) D. De Berardis et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Chronic peripheral inflammation, hippocampal neurogenesis, and behavior

(2016) Vera Chesnokova et al.   BRAIN BEHAVIOR AND IMMUNITY

So depression is an inflammatory disease, but where does the inflammation come from?

(2016) Michael Berk et al.   BMC Medicine

The role of inflammatory cytokines as key modulators of neurogenesis

(2015) Alessandra Borsini et al.   TRENDS IN NEUROSCIENCES

Mechanisms for Interferon-α-Induced Depression and Neural Stem Cell Dysfunction

(2014) Lian-Shun Zheng et al.   Stem Cell Reports

Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness

(2013) Michael Berk et al.   BMC Medicine

Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine

(2013) Raffaella Molteni et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Central administration of murine interferon-α induces depressive-like behavioral, brain cytokine and neurochemical alterations in mice: A mini-review and original experiments

(2012) Shawn Hayley et al.   BRAIN BEHAVIOR AND IMMUNITY

Aspirin attenuates spontaneous recurrent seizures and inhibits hippocampal neuronal loss, mossy fiber sprouting and aberrant neurogenesis following pilocarpine-induced status epilepticus in rats

(2012) Lei Ma et al.   BRAIN RESEARCH

Somatic Drugs for Psychiatric Diseases: Aspirin or Simvastatin for Depression?

(2012) Juan Gibert Rahola   Current Neuropharmacology

Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system

(2012) L.A. Carvalho et al.   JOURNAL OF AFFECTIVE DISORDERS

Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1

(2012) Y. Zhang et al.   JOURNAL OF IMMUNOLOGY

Neuroinflammation, Neurodegeneration, and Depression

(2012) Laura L. Hurley et al.   NEUROTOXICITY RESEARCH

Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2×2 clinical trial

(2012) Jonathan Savitz et al.   BMJ Open

Aspirin decreases the risk of depression in older men with high plasma homocysteine

(2012) O P Almeida et al.   Translational Psychiatry

Association Between Low Serum 25-Hydroxyvitamin D and Depression in a Large Sample of Healthy Adults: The Cooper Center Longitudinal Study

(2011) MinhTu T. Hoang et al.   MAYO CLINIC PROCEEDINGS

Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats

(2011) Ying Wang et al.   NEUROSCIENCE LETTERS

Melatonin agonists in primary insomnia and depression-associated insomnia: Are they superior to sedative-hypnotics?

(2011) Venkatramanujan Srinivasan et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Psychiatric complications of treatment with corticosteroids: Review with case report

(2011) Heather A. Kenna et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Therapeutic potential of melatonin and its analogs in Parkinson’s disease: focus on sleep and neuroprotection

(2011) Venkatramanujam Srinivasan et al.   Therapeutic Advances in Neurological Disorders

Development of a murine animal model of depression for repeated dosing with human interferon alpha

(2011) Chittaranjan Andrade et al.   Indian Journal of Psychiatry

Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice

(2010) Viviane N. de Paiva et al.   BEHAVIOURAL BRAIN RESEARCH

Melatonin: A pleiotropic molecule regulating inflammation

(2010) Flavia Radogna et al.   BIOCHEMICAL PHARMACOLOGY

Norepinephrine and nitric oxide promote cell survival signaling in hippocampal neurons

(2010) Neha J. Patel et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Glucocorticoids, cytokines and brain abnormalities in depression

(2010) Patricia A. Zunszain et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Mechanisms of Non-Opioid Analgesics Beyond Cyclooxygenase Enzyme Inhibition

(2010) May Hamza et al.   Current Molecular Pharmacology

The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1

(2009) J.L. Teeling et al.   BRAIN BEHAVIOR AND IMMUNITY

Amitriptyline is a TrkA and TrkB Receptor Agonist that Promotes TrkA/TrkB Heterodimerization and Has Potent Neurotrophic Activity

(2009) Sung-Wuk Jang et al.   CHEMISTRY & BIOLOGY

Depression, traumatic stress and interleukin-6

(2009) Petr Bob et al.   JOURNAL OF AFFECTIVE DISORDERS

Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders

(2009) Nicholas P. Whitney et al.   JOURNAL OF NEUROCHEMISTRY

Prostaglandins of the E series inhibit monoamine release via EP3 receptors: proof with the competitive EP3 receptor antagonist L-826,266

(2009) J. Günther et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Decreased immobility in swimming test by homologous interferon-α in mice accompanied with increased cerebral tryptophan level and serotonin turnover

(2009) Jianping Wang et al.   NEUROSCIENCE LETTERS

Norepinephrine and serotonin imbalance in the locus coeruleus in bipolar disorder

(2008) Anna K Wiste et al.   BIPOLAR DISORDERS

Antidepressant-like effect of 17β-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems

(2008) Ashish Dhir et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice

(2008) Fraser Murray et al.   EUROPEAN JOURNAL OF PHARMACOLOGY